GB Sciences, Inc is a Las Vegas-based plant-based research and biopharmaceutical drug development company that aims to create patented formulations of plant-inspired prescription medications. With a focus on Parkinson's disease therapies and COVID-related cytokine release syndrome therapies, they have achieved significant results in their animal proof-of-concept studies and have been granted US patents for their innovative treatments. Utilizing their PhAROS Drug Discovery Platform, which incorporates AI technology, GB Sciences identifies and predicts the efficacy of combinations of novel active ingredients from plants.
With a strong emphasis on research and development, GB Sciences collaborates with world-class researchers from international universities to create the future of medicine. Their goal is to preserve the efficacy of plant-based medicines while simplifying their complexity for standardization. By combining their proprietary drug discovery platform and high throughput screening of cell and animal models, GB Sciences creates rationally-designed, minimum essential mixtures for next-generation plant-inspired medicine.
Generated from the website
